The Senior Pharmacometrician develops and implements model-informed drug development (MIDD) plans for drugs and other therapeutic agents in clinical development, partnering with Clinical Pharmacology (CP) and other quantitative functions. MIDD integrates diverse data through pharmacometrics (PMx) models to inform development decisions and regulatory assessments. Applications include dose and regimen selection, clinical study hypotheses, clinical pharmacology and benefit-risk assessments, and health authority interactions. Model-based analyses may also support approval decisions or, in some cases, serve as the primary basis for approval. Model-based meta-analysis (MBMA) provides a quantitative view of competitors and comparators. The role applies PMx methods including population pharmacokinetics/pharmacodynamics, exposure-response, disease progression, and MBMA. Knowledge of modern approaches such as mechanistic modeling (QSP and PBPK), scientific machine learning, and agentic workflows is a significant bonus. The position includes planning, conducting, and reporting analyses, collaborating across functions, contributing to methods and infrastructure, and supporting health authority interactions, generally with some supervision. The position is based in Princeton, New Jersey. Local and international travel for conferences and regulatory meetings may be required depending on project needs, up to 5–10% of the time. The role is identified as #LI-Hybrid, though the posting describes several work models and does not specify the assigned model for this role.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior